复方丹参滴丸联合氯吡格雷治疗冠心病稳定型心绞痛的效果分析OA
Analysis of the Effect of Compound Danshen Dripping Pills Combined with Clopidogrel in the Treatment of Stable Angina in Coronary Heart Disease
目的:探究复方丹参滴丸联合氯吡格雷治疗冠心病稳定型心绞痛的效果.方法:选择2021 年 5 月—2023 年 4 月在贵州茅台医院治疗的冠心病稳定型心绞痛患者 98 例,应用随机数字表法将其分为对照组(氯吡格雷)及观察组(联合复方丹参滴丸),各 49 例.对比两组 24 h动态心电图变化情况[缺血发作次数、持续时间]、血管内皮功能[一氧化氮(NO)、内皮素-1(ET-1)、血管内皮生长因子(VEGF)、可溶性血栓调节蛋白(sTM)]、心脏自主神经功能[低频功率/高频功率(LF/HF)、RR间期标准差(SDNN)、相邻NN间期差值的均方根(RMSSD)]、氧化应激反应[丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)].结果:治疗前,两组 24 h心电图变化比较,差异均无统计学意义(P>0.05);治疗后,两组缺血发作次数均较治疗前减少,缺血持续时间较治疗前均缩短,观察组均优于对照组,差异均有统计学意义(P<0.05).治疗前,两组NO、VEGF、ET-1、sTM比较,差异均无统计学意义(P>0.05);治疗后,两组NO、VEGF均较治疗前升高、ET-1、sTM均降低,观察组NO、VEGF均高于对照组、ET-1、sTM均低于对照组,差异均有统计学意义(P<0.05).治疗前,两组LF/HF、SDNN、RMSSD比较,差异均无统计学意义(P>0.05);治疗后,两组LF/HF、SDNN、RMSSD均较治疗前升高,且观察组均高于对照组,差异均有统计学意义(P<0.05).治疗前,两组SOD、GSH-Px、MDA比较,差异均无统计学意义(P>0.05);治疗后,两组MDA均较治疗前降低,SOD、GSH-Px均升高,观察组MDA低于对照组,SOD、GSH-Px均高于对照组,差异均有统计学意义(P<0.05).结论:复方丹参滴丸联合氯吡格雷治疗冠心病稳定型心绞痛,可改善心肌缺血情况,降低氧化应激反应,改善血管内皮、心脏自主神经功能.
Objective:To explore the effect of Compound Danshen Dripping Pills combined with Clopidogrel in the treatment of stable angina pectoris in coronary heart disease.Method:A total of 98 patients with stable angina pectoris of coronary heart disease who were treated in Kweichow Moutai Hospital from May 2021 to April 2023 were selected,they were divided into control group(Clopidogrel)and observation group(combined with Compound Danshen Dripping Pills)by random number table method,with 49 cases in each group.The changes in 24-hour dynamic electrocardiogram[number and duration of ischemic attacks],vascular endothelial function[nitric oxide(NO),endothelin-1(ET-1),vascular endothelial growth factor(VEGF),soluble thrombomodulin(sTM)],cardiac autonomic function[low-frequency power/high-frequency power(LF/HF),RR interval standard deviation(SDNN),root mean square of adjacent NN interval difference(RMSSD)],oxidative stress response[malondialdehyde(MDA),superoxide dismutase(SOD),glutathione peroxidase(GSH-Px)]were compared between two groups.Result:Before treatment,there were no statistically significant differences in the 24-hour electrocardiogram changes between the two groups(P>0.05);after treatment,the number of ischemic attacks in both groups were decreased compared to those before treatment,the duration of ischemia in both groups was shortened compared to those before treatment,those in the observation group were better than those in the control group,the differences were statistically significant(P<0.05).Before treatment,there were no statistically significant differences in NO,VEGF,ET-1 and sTM between the two groups(P>0.05);after treatment,the levels of NO and VEGF in both groups were increased compared to those before treatment,while ET-1 and sTM were decreased,NO and VEGF in the observation group were higher than those in the control group,ET-1 and sTM were lower than those in the control group,the differences were statistically significant(P<0.05).Before treatment,there were no statistically significant differences in LF/HF,SDNN and RMSSD between the two groups(P>0.05);after treatment,LF/HF,SDNN and RMSSD in both groups were increased compared to those before treatment,and those in the observation group were higher than those in the control group,the differences were statistically significant(P<0.05).Before treatment,there were no statistically significant differences in SOD,GSH-Px and MDA between the two groups(P>0.05);after treatment,MDA levels in both groups were decreased compared to those before treatment,while SOD and GSH-Px levels were increased.MDA level in the observation group was lower than that in the control group,while SOD and GSH-Px levels were higher than those in the control group,the differences were statistically significant(P<0.05).Conclusion:The combination of Compound Danshen Dripping Pills and Clopidogrel in the treatment of stable angina pectoris in coronary heart disease can improve myocardial ischemia,reduce oxidative stress response,and improve vascular endothelial and cardiac autonomic function.
覃智芳;付磊;苟庆林;蒋昭隆;曾国桦
贵州茅台医院心血管内科 贵州 遵义 564500
复方丹参滴丸氯吡格雷冠心病稳定型心绞痛血管内皮功能
Compound Danshen Dripping PillsClopidogrelCoronary heart disease stable anginaVascular endothelial function
《中国医学创新》 2024 (015)
101-105 / 5
贵州省科技计划项目(黔科合成果:20204Y008)
评论